The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report-Reference-Cited by-同舟云学术

The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report

Published:2020-05 Issue: Volume:131 Page:76-88
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Thomas Gillian^ORCID,Eisenhauer Elizabeth,Bristow Robert G.,Grau Cai,Hurkmans Coen,Ost Piet,Guckenberger Matthias,Deutsch Eric,Lacombe Denis,Weber Damien C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Bridging the valley of death: the new Radiotherapy & Oncology section “first in man - translational innovations in radiation oncology;Baumann;Radiother Oncol,2016

2. R-IDEAL: aframework for systematic clinical evaluation of technical innovations in radiation oncology;Verkooijen;Front Oncol,2017

3. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study;Scott;Lancet Oncol,2017

4. A gene signature for selecting benefit from hypoxia modification of radiotherapy for high-risk bladder cancer patients;Yang;Clin Cancer Res,2017

5. Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer;Yang;EBioMedicine,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer;Radiotherapy and Oncology;2024-07

2. Demographic Analysis of Cancer Research Priorities and Treatment Correlations;Current Oncology;2024-03-29

3. Application of BODIPY in photodynamic therapy;AIP Conference Proceedings;2024

4. Heterogeneity in precision oncology;Cambridge Prisms: Precision Medicine;2023-10-05

5. Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers;The Breast;2023-10